Sunday, November 22, 2026
Gustavo Capdevila
- A team UN-backed researchers showed use of the all levonorgestrel contraceptive pill can be effective for emergency contraception, producing less side-effects than other similar treatments.
A paper published in medical journal “The Lancet” Saturday said the research stated the use of levonorgestrel, a synthetic derivative of the hormone progesterone, is more effective and produces less side-effects than the Yuzpe method – the most popular method used at present.
The scientists work for the Special Programme of Research, Development and Training in Human Reproduction (HRP) funded by the United Nations Development Programme (UNDP), its population fund (UNFPA), the World Health Organisation and the World Bank.
HRP director, Paul Van Look, stressed “unplanned pregnancies are a major problem worldwide as many end up being terminated through unsafe abortion.
More than 80,000 women die from this sort of abortion each year, and many tens of thousands more are left with lifelong debilitating illnesses.
The Human Reproduction Programme study confirmed the already existing compound, levonorgestrel, already widely tested, could be used easily and safely to prevent a great number of such unplanned pregnancies.
Levonorgestrel is one of the two active compounds in combined oral contraceptive pills. In the regimen used for emergency contraception, two pills, each containing 0.75 miligrammes of levonorgestrel are administered at an interval of 12 hours.
The Yuzpe method, currently used as a morning-after contraceptive method, dating back to the early eighties is based on a modified regime of combined oestrogen and progesterone oral contraceptive pills.
This is also administered in two doses 12 hours apart. Each dose contains 100 microgrammes of synthetic oestrogen ethinylestradiol and 0.5 miligrammes of levonorgestrel.
The HRP research was carried out in 21 centres distributed around the world, involving 1998 women.
It aimed to compare the efficacity of the two methods (Yuzpe and levonorgestrel) when treatment is started within 72 hours of unprotected sex.
All the women included in the study had requested emergency contraception after a single act of unprotected sexual intercourse.
Each of the women received either levonorgestrel or the Yuzpe regimen and the study waws double blind, neither the doctors nor the women new which treatment had been received.
The failure rate, that is, the percentage of women who became pregnant despite treatment, was higher amongst those who received Yuzpe (3.2 percent) than amongst those who took levonorgestrel (1.1 percent).
Calculation of the number of pregnancies which could have occurred if no treatment had been administered showed levonorgestrel avoided 85 percent of the unwanted pregnancies, compared with 57 percent under the Yuzpe method.
The study also showed that in both groups of women, the pregnancy rate fell when the treatment was administered swiftly.
And apart from being more efficacious, levonorgestrel was better tolerated than Yuzpe. Women from both methods reported the same side-effects: nausea, vomiting, dizziness, fatigue, headache, breast tenderness and low abdominal pain.
However, the secondary effects appeared less frequently amongst women taking levonorgestrel than those treated with the Yuzpe regime.
Doctor Helena von Hertzen, of the HRP, said the study “clearly demonstrated that levonorgestrel outperforms the Yuzpe method in both efficacity and tolerance by users.”